All contributors
Onconephrology contributor
D'Agati, Vivette D
Primarily MGRS & paraprotein kidney disease#15 of 47 recognizedHonor roll
32
Clinical papers
3,136
Citations (iCite)
0 / 17
First / senior author
2001–2025
Active years
Output over time
Clinical corpus papers per year — peak 3 in 2018.
- 2001: 2 papers
- 2003: 2 papers
- 2004: 1 paper
- 2008: 1 paper
- 2009: 1 paper
- 2011: 2 papers
- 2012: 1 paper
- 2013: 1 paper
- 2014: 2 papers
- 2015: 1 paper
- 2016: 2 papers
- 2018: 3 papers
- 2019: 2 papers
- 2020: 3 papers
- 2021: 3 papers
- 2023: 2 papers
- 2024: 1 paper
- 2025: 2 papers
20012025
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
MGRS & paraprotein kidney disease23
Myeloma cast nephropathy18
Anticancer drug nephrotoxicity3
Anti-VEGF / TKI renal effects1
Frequent collaborators
Other recognized contributors who most often share corpus papers with D'Agati (shared-paper count).
Agents they study
Catalog agents whose clinical kidney literature lists D'Agati among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.